Skip to content

IR Zen

Asia News & Headlines, Press Releases & Events

  • Home
  • SeaPRwire
  • EQS Newswire
  • ACN Newswire
  • JCN Newswire
  • Contact

Tag: drug

Posted on January 12, 2023 by: acn

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

       

SINGAPORE, Jan 12, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a …

More ...
Posted on December 15, 2022 by: acn

Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding

       

FREMONT, CA, Dec 14, 2022 – (ACN Newswire via SEAPRWire.com) – Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published …

More ...
Posted on December 6, 2022 by: acn

Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials

       

SYDNEY, AU, Dec 6, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & …

More ...
Posted on November 15, 2022 by: eqs

巨生医MPB-1734抗癌药物新剂型取得成分专利

       

EQS 新闻 via SEAPRWire.com / 2022-11-15 / 10:41 UTC+8 【巨生生医(6827)巨生医MPB-1734取得成分专利新闻稿】 发布日期:2022年11月15日 巨生医MPB-1734抗癌药物新剂型…

More ...
Posted on November 2, 2022 by: jcn

Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of Drug Reexamination

       

TOKYO, Nov 2, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has received notification that Aricept (donepezil hydrochloride), a …

More ...
Posted on October 10, 2022 by: acn

Hua Medicine’s Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China

       

SHANGHAI, CHINA, Oct 10, 2022 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, HKEx Stock Code: 2552.HK) today announces that the New Drug …

More ...
Posted on July 26, 2022 by: acn

Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer

       

Foster City, CA, and Hangzhou, China, Jul 26, 2022 – (ACN Newswire via SEAPRWire.com) – Apollomics Inc. an innovative biopharmaceutical company committed to the discovery …

More ...

网站导航

  • 网站首页
  • SeaPRwire
  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • 财经新闻
  • 商业新闻
  • 国际新闻
  • 联络我们
  • 关于我们
  • RSS订阅

最新资讯

  • BestStock.ai unveils autonomous AI for real-time market analysis and predictive modeling
  • 东吴水泥苏州国资入主 绘就港苏协同新蓝图
  • sureWin Partners with Daesung and the Black Eyed Peas in Landmark Month for Asian Music
  • Ultraman Card Game Original Illustration of “Alien Metron” By Manga Artist Yukinobu Tatsu to be Included in the Upcoming Booster Pack Release
  • IFBH牵手中粮名庄荟 强强联合夯实长远发展根基
  • Professor Lin Xiang Xiong Hosts Landmark Art Exhibition and Peace Prize Ceremony in Paris
  • Opendoor新CEO:一个转折点?
  • 7亿美元加注协鑫科技 发力技术迭代赋能落后产能出清
  • Karbon-X Corp. Files Year-End Financial Results
  • EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes
  • EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes
  • TruMerit Adds Two More Global Credentials for Rehabilitation Care Workers
  • EASD 2025 | 君圣泰医药口头报告HTD1801治疗2型糖尿病临床3期研究成果
  • 财报发布频率的辩论
  • AI云股票跑赢市场领军企业

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • HKBrowse
  • AccessTH
  • AseanTrend
Copyright © 2025 IRZen.com